Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast ...
8h
GlobalData on MSNTripartite MoU signed for mRNA production platform in EgyptFrench company DNA Script will contribute its enzymatic DNA synthesis technologies, while Quantoom of Belgium will bring its ...
While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...
During translation, ribosomes can pause on the nucleic acid. Researchers showed that collisions from incoming proteins get ...
2h
News Medical on MSNNew method for detecting inflammation could revolutionize disease diagnosisNearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues in the human body.
21h
Zacks.com on MSNQiagen (QGEN) Reports Q4 Earnings: What Key Metrics Have to SayAlthough the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall ...
TriLink BioTechnologies & Aldveron ink non-exclusive license and supply agreement for CleanCap mRNA capping technology: San Diego, US Thursday, February 6, 2025, 15:00 Hrs [IST] T ...
Rock and dust samples brought back to Earth from the asteroid Bennu contain organic matter and a variety of minerals crucial to the emergence of life ...
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 1,002 put options on the company.
As India remains the thalassemia capital of the world, the Thalassemia Patients Advocacy Group (TPAG) has written an open ...
RBC Capital analyst Conor McNamara maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report) on February 4 and set a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results